http://www.advfn.com/amex/rss.asp?symbol=PTN Palatin Company Newsfeed en Fri, 07 Sep 2012 08:41:51 EDT Fri, 07 Sep 2012 08:41:51 EDT http://www.advfn.com/amex/StockNews.asp?stocknews=PTN&article=54088725&headline=palatin-tech-says-astrazeneca-halts-further-development-of-obesity http://www.advfn.com/amex/StockNews.asp?stocknews=PTN&article=54088725&headline=palatin-tech-says-astrazeneca-halts-further-development-of-obesity <div class='newsbody'><pre> By Anna Prior </pre> <p> Palatin Technologies Inc. (PTN) said its collaboration partner AstraZeneca PLC (AZN, AZN.LN) has decided to discontinue further development of an obesity drug after a clinical trial for the treatment was halted as a man enrolled in the study became... Fri, 07 Sep 2012 08:41:51 EDT http://www.advfn.com/amex/StockNews.asp?stocknews=PTN&article=52813803&headline=palatin-astrazeneca-obesity-drug-trial-halted-on-adverse-event http://www.advfn.com/amex/StockNews.asp?stocknews=PTN&article=52813803&headline=palatin-astrazeneca-obesity-drug-trial-halted-on-adverse-event <div class='newsbody'><pre> By Kristin Jones </pre> <p> Palatin Technologies Inc. (PTN) said a clinical trial for an obesity drug under development as part of a collaboration with AstraZeneca PLC (AZN, AZN.LN) has been halted after a man enrolled in the study became ill. </p> <p> The safety review committee... Tue, 19 Jun 2012 08:34:05 EDT http://www.advfn.com/amex/StockNews.asp?stocknews=PTN&article=44538841&headline=palatin-tech-4q-loss-widens-sharply-as-revenue-plunges http://www.advfn.com/amex/StockNews.asp?stocknews=PTN&article=44538841&headline=palatin-tech-4q-loss-widens-sharply-as-revenue-plunges <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> Palatin Technologies Inc. (PTN), the biopharmaceutical company that announced major retrenching Friday, said its fiscal fourth-quarter loss widened sharply as revenue plunged. </p> <p> Palatin attributed the wider loss to lower payments from AstraZeneca... Mon, 27 Sep 2010 08:29:05 EDT